Last reviewed · How we verify

Vitamin A — Competitive Intelligence Brief

Vitamin A (Vitamin A) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Essential micronutrient; retinoid. Area: Nutritional deficiency; Immunology; Ophthalmology.

marketed Essential micronutrient; retinoid Retinoid X receptor (RXR), Retinoic acid receptor (RAR) Nutritional deficiency; Immunology; Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin A (Vitamin A) — National Institute of Allergy and Infectious Diseases (NIAID). Vitamin A acts as a ligand for nuclear retinoid receptors, regulating gene expression involved in vision, immune function, and cellular differentiation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vitamin A TARGET Vitamin A National Institute of Allergy and Infectious Diseases (NIAID) marketed Essential micronutrient; retinoid Retinoid X receptor (RXR), Retinoic acid receptor (RAR)
Ascorbic Acid (Vitamin C) Ascorbic Acid (Vitamin C) New York Medical College marketed Vitamin / Essential micronutrient

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Essential micronutrient; retinoid class)

  1. National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin A — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-a. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: